Unique Identifier:
ML-S004
Name on Requisition:
OncoSwift® Colorectal Multi-Omics
Product Line:
ST
Panel Group:
Solid Tumor Panels
Panel Name:
OncoSwift® Colorectal Multi-Omics
Methodology
Molecular
NGS
Test Description and clinical significance
Genes
AKT1, APC, ATM, AXIN2, BRAF, CHEK1, CHEK2, ERBB2, ERBB3, ERBB4, EGFR, FANCA, FBXW7, HRAS, KRAS, MAP2K1, MET, MLH1, MSH2, MSH6, MUTYH, NTRK1, NTRK2, NTRK3, NRAS, PIK3CA, PMS2, POLD1, POLE, PTEN, RET, SMAD4, STK11, TERT, TP53
Disease:
colorectal adenocarcinoma and related malignancies
The OncoSwift® Colorectal Multi-Omics Panel detects mutations and expression changes associated with colorectal adenocarcinoma and related malignancies. This assay identifies driver mutations (e.g., KRAS, NRAS, BRAF), mismatch repair deficiency, and transcriptomic changes, providing critical information for diagnosis, prognosis, and selection of targeted therapies including EGFR inhibitors and immunotherapy.
Specimen Requirements
Preparation:
FFPE tissue or slides
Collection:
In case of FFPE sections, 5-10 sections are recommended at 4 to 10 micron.
Stability:
Stored at room temperature
Unacceptable Conditions:
Specimen submitted is in the incorrect fixative. Insufficient specimen (less than 10% of tumor). Bacterial over growth. Submitted with incomplete requisition form (unless a requisition is subsequently sent). Unlabeled or improperly labeled specimens, without contact information or when failing to
reach the ordering physician for clarification. Decalcified specimens. Improperly stored DNA.
Storage & Transport
Store FFPE blocks and slides at room temperature. Slides may be stored at ambient
CPT(s)
81459
New York Approved
Yes
TAT
7
Requisition Type
ST
Levels of Service
Full
DexS Code
C05C9
Prefix
MI
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.